R.PR
REGISTERED-PRINCIPAL REGISTER
10/28/2025
Back to search
Official data from USPTO
UNIV8 GENOMICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
UNIV8 GENOMICS
ST13
US500000099061189Class
1, 5, 42
Filing
99061189
Registration
8002126
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
10/28/2025
Trademark type
Word
Nice classes
1, 5, 42
Filing date
02/28/2025
Registration date
10/28/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/28/2025
Last transaction
10/28/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Belfast, GB
Examiner
SHANOSKI,JOANNA MARIE
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Univ8 Genomics Ltd
Representatives
Margaret M. Powers Shay Glenn LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in industryscience and photography; Reagents and reagent kits for scientific researchclinical research and medical research use comprising nucleic acidsnaturally occurring or modified nucleotidesenzymeslabelsbuffersfor the purpose of preparingdetectingsequencinganalyzing nucleic acids; Diagnostic preparations for determination of genetic information for scientific or research purposes; Chemical reagents for use in genetic research; Chemical reagents for use in diagnostic testsother than for medical or veterinary use; Diagnostic reagents for scientific or research use; Reagents for medical and clinical research
Class 5
Chemical reagents for medical or veterinary purposes; Chemical reagents for medicalclinical and diagnostic purposes in the field of DNA sequencing and genetics; Chemical reagents for clinical diagnostic purposes; Reagents for analytical purposes for medical purposes; Reagents for medical use; Reagents for use in medical genetic testing
Class 42
Advisory services relating to custom design and development of chemical reagents; Development of computer software for scientific research; development of software for medical diagnostics; development of software for genetic testing; software as a service (SAAS) featuring software for genomic analysis in the field of medical diagnostics; software as a service (SAAS) featuring software for genomic analysis in the field of genetic testing; software as a service (SAAS) featuring software for genomic analysis in the field of healthcare services; informationadvisory and consultancy services in relation to the aforementioned
Publications
History of USPTO decisions and trademark events.
16 publications found
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/09/2025
PUBO
PUBLISHED FOR OPPOSITION
09/09/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/03/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/12/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
08/12/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/12/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
08/12/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/12/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/04/2025
GNRT
NON-FINAL ACTION E-MAILED
08/04/2025
CNRT
NON-FINAL ACTION WRITTEN
08/04/2025
DOCK
ASSIGNED TO EXAMINER
08/04/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/22/2025
MAFR
APPLICATION FILING RECEIPT MAILED
02/28/2025
NWAP
NEW APPLICATION ENTERED
02/28/2025
Continuous trademark protection
Get notified about every new filing that threatens UNIV8 GENOMICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.